Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06945848
What this trial is testing

Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide

Who this might be right for
Idiopathic Intracranial Hypertension (IIH)
University Hospital, Montpellier 114
Testing effectiveness (Phase 2)Ended earlyNCT01999192
What this trial is testing

Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biotest 321
Large-scale testing (Phase 3)UnknownNCT04956328
What this trial is testing

Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

Who this might be right for
Primary Biliary Cirrhosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 120
Post-approval studies (Phase 4)Ended earlyNCT04533737
What this trial is testing

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

Who this might be right for
Plaque PsoriasisPsoriasis VulgarisPsoriasis
LEO Pharma 113
Large-scale testing (Phase 3)Study completedNCT06715319
What this trial is testing

Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis

Who this might be right for
PBC
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 100
Large-scale testing (Phase 3)Looking for participantsNCT06389136
What this trial is testing

Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06867042
What this trial is testing

Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

Who this might be right for
Ulcerative Colitis (UC)Ulcerative Colitis, Active Moderate
Jina Pharmaceuticals Inc. 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07665996
What this trial is testing

A Phase Ib/IIa Study Assessing the Rapid Onset Characteristics of TLL-018 for Moderate-to-Severe CSU With Inadequate Response to Second-Generation H1 Antihistamines

Who this might be right for
Chronic Spontaneous Urticaria (CSU)
Hangzhou Highlightll Pharmaceutical Co., Ltd 36
Large-scale testing (Phase 3)Study completedNCT03660059
What this trial is testing

Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)

Who this might be right for
Rheumatoid Arthritis (RA)
Astellas Pharma China, Inc. 385
Large-scale testing (Phase 3)Study completedNCT01211834
What this trial is testing

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
JW Pharmaceutical 90
Large-scale testing (Phase 3)Study completedNCT01721057
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 684
Large-scale testing (Phase 3)Study completedNCT01152554
What this trial is testing

Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderMDDDepression
AstraZeneca 813
Large-scale testing (Phase 3)Study completedNCT04269707
What this trial is testing

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044

Who this might be right for
Iron Deficiency Anemia
American Regent, Inc. 7
Testing effectiveness (Phase 2)WithdrawnNCT05165771
What this trial is testing

Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences
Testing effectiveness (Phase 2)Study completedNCT00886795
What this trial is testing

Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy

Who this might be right for
Urticaria
Johns Hopkins University 4
Large-scale testing (Phase 3)Study completedNCT01126541
What this trial is testing

SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 224
Testing effectiveness (Phase 2)Ended earlyNCT04421456
What this trial is testing

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Who this might be right for
Schizophrenia
Jazz Pharmaceuticals 95
Testing effectiveness (Phase 2)Ended earlyNCT01651936
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)

Who this might be right for
Rheumatoid Arthritis
Merck Sharp & Dohme LLC 56
Large-scale testing (Phase 3)Active Not RecruitingNCT05782907
What this trial is testing

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
AbbVie 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07764003
What this trial is testing

Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHs

Who this might be right for
Chronic Spontaneous Urticaria (CSU)
Hangzhou Highlightll Pharmaceutical Co., Ltd 140
Next Page